- AU$149.74m
- AU$106.76m
- AU$16.23m
Brief: Orthocell Seeks Trading Halt
Brief: Orthocell Posts FY Total Revenues From Continuing Operations Of A$1.8 Million
Brief: Orthocell Signs Striate Global License And Manufacturing Agreement
Brief: Orthocell Ltd Seeks Trading Halt
Brief: Orthocell Ltd Receives A$2.1M Research And Development Tax Incentive Refund
Australia's Orthocell leaps on regulatory nod for medical device
Brief: Orthocell Ltd Gets Regulatory Approval For Remplir Nerve Repair Device-OCC.Ax
Australia Stock Exchange release from ORTHOCELL : PRE_NR Ends: 10:45:57
Australia Stock Exchange release from ORTHOCELL : Regulatory Approval for Remplir Nerve Repair Device
Brief: Orthocell Ltd Seeks Trading Halt
Australia Stock Exchange release from ORTHOCELL : Trading Halt
Australia Stock Exchange release from ORTHOCELL : Pause in Trading
Australia Stock Exchange release from ORTHOCELL : Striate US Market Entry Update
Australia Stock Exchange release from ORTHOCELL : PRE_NR Ends: 09:35:11
Australia Stock Exchange release from ORTHOCELL : PRE_NR Ends: 18:44:35
Australia Stock Exchange release from ORTHOCELL : Half Yearly Report and Accounts
Australia Stock Exchange release from ORTHOCELL : PRE_NR Ends: 17:59:14
Australia Stock Exchange release from ORTHOCELL : Appendix 4C - Quarterly
Australia Stock Exchange release from ORTHOCELL : Notice under Section 708(A) of the Corporations Act